![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
The item has been added to your shopping cart.
Home » Celator Pharma Initiates Clinical Study in Patients With Untreated MDS/AML
Celator Pharma Initiates Clinical Study in Patients With Untreated MDS/AML
August 16, 2013
Celator is enrolling patients in a trial to test CPX-351 injections for patients with untreated high-risk myelodysplastic syndrome or acute myeloid leukemia.
Pharmabiz.com
Pharmabiz.com
Upcoming Events
-
21Oct